Guggenheim analyst Subbu Nambi reiterated a Buy rating and $55.00 price target on Twist Bioscience (NASDAQ: TWST).The analyst commented: "Today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments